Nutrition 21 Receives Commitment from Rite Aid Corporation for its Chromax(R) Product; First Time Chromax Brand To Be Sold in Retail Stores

01/13/2006 06:57 PM

Nutrition 21, Inc., (NASDAQ: NXXI) today announced that it has received a purchase order from Rite Aid Corporation for the Company's Chromax(R) chromium picolinate product. Rite Aid will distribute...

 

Nutrition 21 Appoints Dean DiMaria to Vice President of Sales and Marketing

12/13/2005 05:00 AM

Nutrition 21, Inc., (NASDAQ: NXXI) the leading developer and marketer of chromium-based nutritional supplements, today announced the appointment of Dean DiMaria as the Company’s Vice President of S...

 

Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax(R) Chromium Picolinate Inclusion in FiberChoice(R) Weight Management Chewable Tablets

10/31/2005 05:00 AM

Nutrition 21, Inc., (NASDAQ: NXXI) today announced a supply & licensing agreement with CNS, Inc, the Breathe Right® * company, for the exclusive use of Chromax® chromium picolinate as an ingredient...

 

NEW STUDY PUBLISHED IN LEADING TOXICOLOGY JOURNAL CONCLUDES CHROMAX® CHROMIUM PICOLINATE IS SAFE

10/24/2005 05:00 AM

Nutrition 21, Inc., (NASDAQ: NXXI) today announced results of a new study that found Chromax® chromium picolinate does not produce chromosomal aberrations in Chinese Hamster Ovary (CHO) cells.

 

Chromium Picolinate Linked With Reduced Carbohydrate Cravings In People With Atypical Depression

09/29/2005 05:00 AM

A randomized, double-blind, placebo-controlled study assessing chromium picolinate supplementation in 113 people with atypical depression found that a subset of patients who reported the highest le...

 

Nutrition 21 Reports Fiscal Fourth-Quarter And Full-Year 2005 Results

09/27/2005 05:00 AM

Nutrition 21, Inc. (NASDAQ: NXXI), the leading developer and marketer of chromium-based nutritional supplements, today announced financial results for the fourth quarter and fiscal year ended June ...

 

Study Results Show Diachrome® Improves Poorly-Controlled Blood Sugar Levels for People on Antidiabetic Prescription Medications

09/12/2005 10:00 PM

Nutrition 21 (NASDAQ: NXXI) — A sub-set analysis from a Diachrome XLHealth clinical trial demonstrates that adding daily supplementation with Diachrome to prescription treatment regimens can signif...

 

Nutrition 21 and Dong Sung Pharmaceuticals Enter into Distribution Agreement for Chromax® and Diachrome®

09/08/2005 05:00 AM

Nutrition 21, Inc. (Nasdaq: NXXI), the leading developer and marketer of chromium-based nutritional supplements, announced today that it has entered into an exclusive distribution agreement with Do...

 

Diachrome® Supplementation Associated with Potential Cost Savings of $52.9 Billion for People with Diabetes

08/31/2005 05:00 AM

Nutrition 21, Inc. (Nasdaq: NXXI) reported that an economic analysis conducted by researchers in the Department of Health Policy at Thomas Jefferson University in Philadelphia shows that use of Dia...

 

FDA APPROVES FIRST QUALIFIED HEALTH CLAIM FOR CHROMIUM PICOLINATE AND RISK OF TYPE 2 DIABETES

08/29/2005 05:00 AM

The U.S. Food & Drug Administration (FDA) issued a favorable response to a qualified health claim petition filed by Nutrition 21, recognizing chromium picolinate as a safe nutritional supplement th...

 

Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax® Chromium Picolinate and Zinmax® Zinc Picolinate

08/02/2005 05:00 AM

Nutrition 21, Inc., (NASDAQ: NXXI) the leading developer and marketer of chromium-based nutritional supplements, today announced that it has received “derogation” (approval for continued sale) in m...